Nexvet Biopharma plc·4

Jul 5, 12:28 PM ET

Nexvet Biopharma plc 4

4 · Nexvet Biopharma plc · Filed Jul 5, 2017

Insider Transaction Report

Form 4
Period: 2017-06-30
Hanna Ashraf
Director
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2017-06-30$0.13/sh+500$6312,420 total
  • Exercise/Conversion

    Ordinary Shares

    2017-07-01$0.13/sh+3,600$45016,020 total
  • Exercise/Conversion

    Restricted Share Units

    2017-07-013,6000 total
    Exercise: $0.13From: 2017-07-01Exp: 2021-07-01Ordinary Shares (3,600 underlying)
  • Exercise/Conversion

    Restricted Share Units

    2017-06-305000 total
    Exercise: $0.13From: 2017-06-30Exp: 2019-07-01Ordinary Shares (500 underlying)
Holdings
  • Ordinary Shares

    (indirect: By Trust)
    1,500

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT